Ciclesonide
Tier C — Watch / tradeCiclesonide
Targets:GR
Brand:Omnaris, Omnaris HFA, Omnair, Osonase, Zetonna, Alvesco, Osonide, Zetonna/Omnaris/Alvesco, Alvesco HFA
Indications (approved):Asthma, Perennial allergic rhinitis, Seasonal allergic rhinitis, Allergic rhinitis
Regional status
Synthetic routes & intermediates5 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| CICL-001 | 13951-70-7 | (8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| CICL-002 | 97-72-3 | isobutyric anhydride |
| CICL-003 | 141700-34-7 | (8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-17-(2-(isobutyryloxy)acetyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-16,17-diyl bis(2-methylpropanoate) |
| CICL-004 | 2043-61-0 | cyclohexanecarbaldehyde |
| CICL-005 | 204444-45-1 | 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate |
| Code | CAS No. | Intermediate |
|---|---|---|
| CICL-002 | 97-72-3 | isobutyric anhydride |
| CICL-004 | 2043-61-0 | cyclohexanecarbaldehyde |
| CICL-006 | 638-94-8 | (6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one |
| CICL-007 | 78806-61-8 | 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate |
| Code | CAS No. | Intermediate |
|---|---|---|
| CICL-001 | 13951-70-7 | (8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| CICL-002 | 97-72-3 | isobutyric anhydride |
| CICL-004 | 2043-61-0 | cyclohexanecarbaldehyde |
| CICL-008 | - | (6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one |
| CICL-009 | 1015172-34-5 | 2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate |
| CICL-010 | 161115-59-9 | (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one |
| Code | CAS No. | Intermediate |
|---|---|---|
| CICL-004 | 2043-61-0 | cyclohexanecarbaldehyde |
| CICL-011 | - | (8S,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-13-methyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| CICL-012 | 1451396-66-9 | (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-8b-(2-bromoacetyl)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one |
| CICL-013 | 996-30-5 | sodium isobutyrate |
| Code | CAS No. | Intermediate |
|---|---|---|
| CICL-004 | 2043-61-0 | cyclohexanecarbaldehyde |
| CICL-010 | 161115-59-9 | (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one |
| CICL-011 | - | (8S,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-13-methyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| CICL-014 | 36609-97-9 | sodium cyclohexyl(hydroxy)methanesulfonate |
| CICL-015 | 79-30-1 | isobutyryl chloride |
Frequently asked questions
What are the approved indications of Ciclesonide?
Approved indications include: Asthma, Perennial allergic rhinitis, Seasonal allergic rhinitis, Allergic rhinitis.
When does the Ciclesonide patent expire?
No public expiry year is available for Ciclesonide yet; this page updates once verified.
How many synthesis routes are recorded for Ciclesonide?
5 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Ciclesonide intermediates?
All intermediates in Ciclesonide routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Ciclesonide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27